Author:
Topazio L.,Perugia C.,De Nunzio C.,Gaziev G.,Iacovelli V.,Bianchi D.,Vespasiani G.,Finazzi Agrò E.
Publisher
Springer Science and Business Media LLC
Subject
Urology,Reproductive Medicine,General Medicine
Reference28 articles.
1. Platz EA, Smit E, Curhan GC, Nyberg LM, Giovannucci E. Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology. 2002;59:877–83.
2. Martin SA, Haren MT, Marshall VR, et al. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011;29:179–84.
3. EAU guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO)S. Gravas (Chair), T. Bach, A. Bachmann, M. Drake, M. Gacci, C. Gratzke, S. Madersbacher, C. Mamoulakis, K.A.O. Tikkinen Guidelines Associates: M. Karavitakis, S. Malde, V. Sakkalis, R. Umbach. LIMITED UPDATE MARCH 2016.
4. Mc Connell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, a combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349:2387–98.
5. Lepor H. Long term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. The terazosin research group. Urology. 1995;45:406–13.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献